What is Enterococcus faecalis?
Enterococcus faecalis is a Gram-positive, facultative anaerobic bacterium that normally inhabits the human gastrointestinal tract as a commensal organism but can act as an opportunistic pathogen, particularly in immunocompromised patients and healthcare settings.
Basic Microbiology and Normal Role
E. faecalis is a ubiquitous member of the healthy human gut microbiota that colonizes the intestines from early life 1, 2. As a commensal organism, it performs beneficial functions including:
- Vitamin production
- Nutrient metabolism
- Maintenance of intestinal pH 1
The bacterium exists in a symbiotic relationship with its host, receiving a niche to inhabit in exchange for these metabolic contributions 1.
Pathogenic Potential
E. faecalis transforms from a benign commensal to a dangerous pathogen when host defenses are compromised. This dual nature—beneficial commensal versus opportunistic pathogen—explains its designation as a "Dr. Jekyll and Mr. Hyde" organism 2.
Clinical Significance
The bacterium is a leading cause of nosocomial (hospital-acquired) infections, with increasing prevalence in healthcare settings 3, 1. Common infection sites include:
- Urinary tract infections (most common)
- Bloodstream infections (bacteremia/sepsis)
- Intra-abdominal infections
- Infective endocarditis (particularly mitral valve) 3
- Wound infections
- Root canal infections (secondary apical periodontitis) 4, 5
Distinguishing E. faecalis from E. faecium
E. faecalis differs from its related species E. faecium in several clinically important ways 3:
- E. faecalis: Associated with mitral valve endocarditis, central venous line infections, and liver transplantation
- E. faecium: Associated with tricuspid valve endocarditis and generally higher mortality rates when vancomycin-resistant
Virulence Mechanisms
E. faecalis possesses multiple virulence factors that enable pathogenicity 5:
- Biofilm formation (66% of isolates in root canal failures) 5
- Gelatinase production (gelE gene) 6
- Hemolysin production
- Surface rhamnopolysaccharide (epa) for intestinal colonization 7
- Immune evasion capabilities through suppression and inactivation of innate and adaptive immune responses 2
A critical finding is the strong negative correlation (r = -0.88) between biofilm formation and antibiotic susceptibility—strains that produce biofilms exhibit significantly greater antibiotic resistance 5.
Antimicrobial Resistance Profile
Vancomycin Resistance
Vancomycin-resistant Enterococcus (VRE) has become increasingly prevalent since first emerging in 1988 3. The U.S. CDC reports non-susceptibility rates of 7.2% for E. faecium to 82.1% for E. faecalis in device-associated healthcare infections 3. However, this appears to be an error in the source document, as typically E. faecium has higher vancomycin resistance rates than E. faecalis.
Common Resistance Patterns
Based on recent isolate data 5:
- Complete resistance: Metronidazole (100%)
- High resistance: Ciprofloxacin (66%), tetracycline (64%), erythromycin (60%), ampicillin (44%)
- Complete susceptibility: Amoxicillin-clavulanic acid, vancomycin, piperacillin-tazobactam
Pathophysiology of Infection
E. faecalis transitions from commensal to pathogen through a specific sequence 7:
- Disruption of intestinal homeostasis (antibiotics, illness, immunosuppression)
- Overgrowth in the gut
- Translocation across intestinal barrier
- Entry into lymphatic system and bloodstream
- Dissemination to distant sites
The bacterium's metabolic plasticity allows rapid adaptation to new environments, enabling persistence in multiple anatomical niches 2.
Immune System Interactions
E. faecalis has evolved sophisticated mechanisms to subvert host immunity 8, 2:
- Produces extracellular vesicles (Ef-EVs) that activate pro-inflammatory responses via Toll-like receptor 2 (TLR2) signaling
- Induces metabolic reprogramming in macrophages toward a pro-inflammatory, glycolytic phenotype
- Disrupts normal immune cell functions, hindering bacterial eradication 4
- Importantly, inflammatory activation occurs at the plasma membrane without requiring bacterial internalization 8
Clinical Implications
It is critical to differentiate colonization from true infection before initiating anti-enterococcal therapy 3. Not all E. faecalis detection requires treatment, as it may represent normal gut flora or asymptomatic colonization rather than active infection.
The increasing role of E. faecalis in nosocomial infections, combined with its antimicrobial resistance and biofilm-forming capabilities, makes it a progressively more dangerous opponent in healthcare settings 1, 5.